Avance Clinical is the CRO for Biotechs. We are the largest full-service Australian CRO - now with US operations - specializing in delivering quality clinical trials, with globally accepted data. Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, has been providing CRO services in the region for the past 26 years. Avance Clinical offers pre-clinical services with their experienced ClinicReady team right through to Phases 1 and 2 leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes. With experience across more than 105 indications the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review. Avance Clinical delivers customised solutions designed around specific client needs rather than a one size fits all approach. As a company, Avance Clinical has focused on state-of-the-art technology and systems across all functional areas to provide clients